Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 19/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31448252 | 0.87 | PPOX (0.53) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL31448249 | 0.87 | PPOX (0.53) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL11130699 | 0.86 | PPOX (0.64) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL10930233 | 0.81 | PPOX (0.59) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL9638953 | 0.81 | MEN1 (0.62) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL29423792 | 0.80 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL38813 | 0.80 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL14539218 | 0.80 | PPOX (0.71) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL1068568 | 0.80 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL21633846 | 0.79 | PPOX (0.98) | PPOXMEN1KMT2ATDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070123425-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123425-A1 | AQUEOUS SUSPENSION CONCENTRATES | AS3MT, ASH2L, ATL3 | PPOX 1197/4885MEN1 4264/4885KMT2A 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.